AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36355674 — intervention group
Group type: COMPARATOR
Intervention: Neutral control task (Study 2)
Number of subjects: 574
Study 33499876 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-completed EQ-5D-5L
Number of subjects: 120
Study 33499876 — intervention group
Group type: COMPARATOR
Intervention: Proxy-patient version of EQ-5D-5L
Number of subjects: 120
Study 33499876 — intervention group
Group type: COMPARATOR
Intervention: Proxy-proxy version of EQ-5D-5L
Number of subjects: 120
Study 33499876 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS-Health score from patients
Number of subjects: 120
Study 33499876 — intervention group
Group type: COMPARATOR
Intervention: VAS-Health score from proxy-proxy perspective
Number of subjects: 120
Study 33499876 — intervention group
Group type: COMPARATOR
Intervention: VAS-Health score from proxy-patient perspective
Number of subjects: 120
Study 35879211 — intervention group
Group type: EXPERIMENTAL
Intervention: Reality television-style singing
Number of subjects: 212
Study 35879211 — intervention group
Group type: EXPERIMENTAL
Intervention: Amateur singing
Number of subjects: 212
Study 35879211 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional plain singing
Number of subjects: 212
Study 35879211 — intervention group
Group type: COMPARATOR
Intervention: Control version (piano, no singing)
Number of subjects: 212
Study 35879211 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional singing in the style of reality television singing
Number of subjects: 212
Study 34242101 — intervention group
Group type: EXPERIMENTAL
Intervention: 2'-O-methoxyethyl (2?MOE) modified ASOs
Number of subjects: 713
Study 34242101 — intervention group
Group type: COMPARATOR
Intervention: Mipomersen (control)
Number of subjects: 713
Study 35050303 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT
Number of subjects: 3410
Study 35050303 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT+BT
Number of subjects: 3410
Study 35050303 — intervention group
Group type: COMPARATOR
Intervention: EBRT (DART)
Number of subjects: 3410
Study 33314365 — intervention group
Group type: EXPERIMENTAL
Intervention: New model for predicting AKI
Number of subjects: 848
Study 33314365 — intervention group
Group type: EXPERIMENTAL
Intervention: New model
Number of subjects: 848
Study 33314365 — intervention group
Group type: COMPARATOR
Intervention: Cleveland Clinic score
Number of subjects: 848
Study 33314365 — intervention group
Group type: COMPARATOR
Intervention: Simplified Renal Index (SRI) score
Number of subjects: 848
Study 36250257 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 36250257 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0
Study 36250257 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33389313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0-mg/kg/day Tripterygium wilfordii Hook F. (TwHF)
Number of subjects: 30
Study 33389313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5-mg/kg/day Tripterygium wilfordii Hook F. (TwHF)
Number of subjects: 30
Study 35932954 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention showing values communication between cancer patient-caregivers
Number of subjects: 42
Study 35932954 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 34698813 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-polysaccharide Conjugate Vaccine
Number of subjects: 0
Study 33782018 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention embedded into GP practice IT systems including parental concerns elicitation, prognostic algorithm results, and prescribing guidance.
Number of subjects: 310
Study 33782018 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 310
Study 32652112 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutations (58.8%)
Number of subjects: 764
Study 32652112 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplifications on chromosome 8p11 (10.9%)
Number of subjects: 764
Study 32652112 — intervention group
Group type: EXPERIMENTAL
Intervention: BRCA2 mutations (2.3%)
Number of subjects: 764
Study 36112819 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-velocity resistance exercise
Number of subjects: 60
Study 36112819 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity resistance exercise
Number of subjects: 60
Study 36112819 — intervention group
Group type: COMPARATOR
Intervention: Both low- and high-velocity resistance exercises
Number of subjects: 60
Study 34515607 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist access
Number of subjects: 347
Study 34515607 — intervention group
Group type: COMPARATOR
Intervention: No checklist access
Number of subjects: 347
Study 33217618 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 10‐mg/ml
Number of subjects: 220
Study 33217618 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 40‐mg/ml
Number of subjects: 220
Study 33217618 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 100‐mg/ml
Number of subjects: 220
Study 33217618 — intervention group
Group type: COMPARATOR
Intervention: Monthly intravitreal ranibizumab 0.5‐mg
Number of subjects: 220
Study 32126551 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC601
Number of subjects: 1087
Study 32126551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1087
Study 32019378 — intervention group
Group type: EXPERIMENTAL
Intervention: EmbaGYN device (Group 1, n = 40)
Number of subjects: 70
Study 32019378 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic Kegel Master device (Group 2, n = 40)
Number of subjects: 70
Study 34214289 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing Professional Values scale (NPVS‐3)
Number of subjects: 124
Study 34214289 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring domain (10 items)
Number of subjects: 124
Study 34214289 — intervention group
Group type: EXPERIMENTAL
Intervention: Activism domain (10 items)
Number of subjects: 124
Study 34214289 — intervention group
Group type: EXPERIMENTAL
Intervention: Professionalism domain (8 items)
Number of subjects: 124
Study 34214289 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience level of nurses
Number of subjects: 124
Study 35288513 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) + HMB supplementation (1500 mg daily)
Number of subjects: 156
Study 35288513 — intervention group
Group type: COMPARATOR
Intervention: Education + HMB supplementation (1500 mg daily)
Number of subjects: 156
Study 35288513 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) + Placebo
Number of subjects: 156
Study 35288513 — intervention group
Group type: COMPARATOR
Intervention: Education + Placebo
Number of subjects: 156
Study 33246482 — intervention group
Group type: EXPERIMENTAL
Intervention: PK-guided dosing of hydroxyurea
Number of subjects: 0
Study 33246482 — intervention group
Group type: COMPARATOR
Intervention: Standard weight-based dosing of hydroxyurea (20 mg/kg/day)
Number of subjects: 0
Study 34578981 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Load (LGL) diet
Number of subjects: 12
Study 34578981 — intervention group
Group type: COMPARATOR
Intervention: High Glycemic Load (HGL) diet
Number of subjects: 12
Study 32776933 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating raw fish 12–50 times in the last year
Number of subjects: 2521
Study 32776933 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating raw fish >50 times in the last year
Number of subjects: 2521
Study 36460332 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical Anemia Bundle for Sustained Blood Recovery (PABST-BR)
Number of subjects: 0
Study 36460332 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 36271976 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Health Home Plus (BHHP) model implementation training through Learning Collaborative (LC)
Number of subjects: 12
Study 36271976 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Collaborative (LC) approach
Number of subjects: 12
Study 33543872 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting Multidisciplinary Program
Number of subjects: 0
Study 33543872 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32315981 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity activity breaks
Number of subjects: 30
Study 32315981 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity activity breaks
Number of subjects: 30
Study 32315981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity activity breaks
Number of subjects: 30
Study 32315981 — intervention group
Group type: COMPARATOR
Intervention: Sedentary breaks
Number of subjects: 30
Study 35685676 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.2 mg/kg intravenously
Number of subjects: 110
Study 35685676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg intravenously + Nalbuphine 0.2 mg/kg
Number of subjects: 110
Study 35685676 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Saline
Number of subjects: 110
Study 34868333 — intervention group
Group type: EXPERIMENTAL
Intervention: Wenbu Zhibi Granule (WZG)
Number of subjects: 100
Study 36477734 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg
Number of subjects: 448
Study 36477734 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 448
Study 36477734 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 448
Study 36477734 — intervention group
Group type: COMPARATOR
Intervention: Overall preference allocation
Number of subjects: 448
Study 33413212 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional oral care (POC)
Number of subjects: 174
Study 33413212 — intervention group
Group type: COMPARATOR
Intervention: Control (no professional oral care)
Number of subjects: 174
Study 35552287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 70
Study 35552287 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 70
Study 34478863 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical benzoyl peroxide (BPO) gel applied for a total of 5 treatments
Number of subjects: 60
Study 34478863 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue light therapy (BLT), single 23‐minute treatment at 40 mW/cm2
Number of subjects: 60
Study 34478863 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of BPO followed by BLT
Number of subjects: 60
Study 34478863 — intervention group
Group type: COMPARATOR
Intervention: Control group (contralateral shoulders)
Number of subjects: 60
Study 32317212 — intervention group
Group type: EXPERIMENTAL
Intervention: In-bed cycling intervention
Number of subjects: 0
Study 35790298 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypectomy with cutting current (PCC)
Number of subjects: 49
Study 35790298 — intervention group
Group type: COMPARATOR
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 49
Study 33811051 — intervention group
Group type: EXPERIMENTAL
Intervention: DCD allograft in addition to standard care
Number of subjects: 196
Study 33811051 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 196
Study 32529588 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser 808 nm combined with TheraCal LC
Number of subjects: 14
Study 32529588 — intervention group
Group type: COMPARATOR
Intervention: TheraCal LC alone
Number of subjects: 14
Study 34866029 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with low-intensity shockwave therapy (LiST) and tadalafil
Number of subjects: 50
Study 34866029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35415565 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-canceling headphones and music during surgery
Number of subjects: 50
Study 35415565 — intervention group
Group type: COMPARATOR
Intervention: Control group (no headphones or music)
Number of subjects: 50
Study 35415565 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study 33188164 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy
Number of subjects: 203
Study 33188164 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (HCT)
Number of subjects: 203
Study 33188164 — intervention group
Group type: COMPARATOR
Intervention: Historical control series (not specified)
Number of subjects: 203
Study 35225793 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-based bioresorbable scaffolds (MgBRS)
Number of subjects: 142
Study 35225793 — intervention group
Group type: COMPARATOR
Intervention: Permanent metallic sirolimus-eluting stents (SES)
Number of subjects: 142
Study 32928237 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-sensitized radiation therapy combined with pembrolizumab
Number of subjects: 0
Study 34413247 — intervention group
Group type: EXPERIMENTAL
Intervention: RD/eSLD
Number of subjects: 110
Study 34413247 — intervention group
Group type: COMPARATOR
Intervention: RD/CD
Number of subjects: 110
Study 34413247 — intervention group
Group type: COMPARATOR
Intervention: FTF/CD
Number of subjects: 110
Study 33296389 — intervention group
Group type: EXPERIMENTAL
Intervention: subcaudal pholidosis
Number of subjects: 0
Study 33296389 — intervention group
Group type: EXPERIMENTAL
Intervention: ventral body markings
Number of subjects: 0
Study 33296389 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of both measures
Number of subjects: 0
Study 35943743 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (30-minute session after 50 mg/2 mL diclofenac sodium intramuscular injection)
Number of subjects: 80
Study 33641473 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive high-frequency oscillatory ventilation (NHFOV)
Number of subjects: 149
Study 33641473 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 149
Study 33641473 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 149
Study 33641473 — intervention group
Group type: EXPERIMENTAL
Intervention: NHFOV and NIPPV
Number of subjects: 149
Study 33641473 — intervention group
Group type: EXPERIMENTAL
Intervention: NHFOV
Number of subjects: 149
Study 32425222 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) + standard treatment
Number of subjects: 0
Study 32425222 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 35232215 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA+DPA-FFA
Number of subjects: 100
Study 35232215 — intervention group
Group type: COMPARATOR
Intervention: EPA-EE
Number of subjects: 100
Study 34503983 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone monotherapy (4 months)
Number of subjects: 191
Study 34503983 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone-itraconazole combination (4 and 6 months)
Number of subjects: 191
Study 34503983 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 191
Study 34736499 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 83
Study 34736499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 34536666 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) for 10 minutes daily for three consecutive days
Number of subjects: 103
Study 34536666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study 34687360 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 60
Study 34687360 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 60
Study 34687360 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIIT and MICT
Number of subjects: 60
Study 32902205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous milrinone
Number of subjects: 20
Study 32902205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32902205 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (in vivo studies in sheep)
Number of subjects: 20
Study 35857396 — intervention group
Group type: EXPERIMENTAL
Intervention: Rater training intervention (in-person training followed by asynchronous online spaced learning)
Number of subjects: 94
Study 35857396 — intervention group
Group type: EXPERIMENTAL
Intervention: Rater training intervention
Number of subjects: 94
Study 35857396 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rater training)
Number of subjects: 94
Study 33146811 — intervention group
Group type: EXPERIMENTAL
Intervention: modified endoscopic retrograde appendicitis therapy (mERAT)
Number of subjects: 83
Study 33146811 — intervention group
Group type: COMPARATOR
Intervention: antibiotic treatment
Number of subjects: 83
Study 32433915 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy performed by a fellow under the supervision of a staff endoscopist
Number of subjects: 812
Study 32433915 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy performed by an attending physician alone
Number of subjects: 812
Study 35418080 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cycles of R-CHOP followed by 2 additional cycles of rituximab monotherapy for patients with negative interim PET/CT
Number of subjects: 129
Study 35418080 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cycles of R-CHOP
Number of subjects: 129
Study 35418080 — intervention group
Group type: COMPARATOR
Intervention: 6 cycles of R-CHOP
Number of subjects: 129
Study 35418080 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cycles of R-CHOP followed by 2 cycles of rituximab
Number of subjects: 129
Study 35418080 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive interim PET/CT
Number of subjects: 129
Study 35418080 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative interim PET/CT
Number of subjects: 129
Study 33540241 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine at 0.7 mg/kg/day
Number of subjects: 0
Study 33540241 — intervention group
Group type: COMPARATOR
Intervention: Fenfluramine
Number of subjects: 0
Study 32479794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepotinib 500 mg plus gefitinib 250 mg once daily (phase 2)
Number of subjects: 73
Study 32479794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepotinib plus gefitinib in patients with high MET overexpression (IHC3+)
Number of subjects: 73
Study 32479794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepotinib plus gefitinib in patients with MET amplification
Number of subjects: 73
Study 32479794 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 73
Study 34201795 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed precision prevention materials
Number of subjects: 1134
Study 34201795 — intervention group
Group type: COMPARATOR
Intervention: Generic prevention materials
Number of subjects: 1134
Study 35124345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodyweight supported treadmill training (BWSTT)
Number of subjects: 40
Study 35124345 — intervention group
Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 40
Study 34650619 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide powder inhalation (18 μg, inhalation, QD)
Number of subjects: 120
Study 34650619 — intervention group
Group type: COMPARATOR
Intervention: Formoterol fumarate powder inhalation (12 μg, inhalation, BID) plus ambroxol hydrochloride tablets (60 mg, oral, TID)
Number of subjects: 120
Study 35133557 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning Your Temper (cognitive behavioral program)
Number of subjects: 125
Study 35133557 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 125
Study 33228459 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg) administered on the third postoperative day with standard analgesia (ibuprofen and acetaminophen)
Number of subjects: 119
Study 33228459 — intervention group
Group type: COMPARATOR
Intervention: Standard analgesia (ibuprofen and acetaminophen) without dexamethasone
Number of subjects: 119
Study 35032643 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate (KNO3) 1300 mg (12.8 mmol)
Number of subjects: 16
Study 35032643 — intervention group
Group type: COMPARATOR
Intervention: Potassium chloride (KCl)
Number of subjects: 16
Study 34530317 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion induction
Number of subjects: 59
Study 34530317 — intervention group
Group type: COMPARATOR
Intervention: No-strategy control induction
Number of subjects: 59
Study 36175942 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigator intervention
Number of subjects: 0
Study 36175942 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted)
Number of subjects: 0
Study 34316171 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with statistically significant results
Number of subjects: 100
Study 34316171 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with statistically insignificant results
Number of subjects: 100
Study 34316171 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall RCTs analyzed
Number of subjects: 100
Study 34871832 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze-based training intervention using video-based expert commentary and 3M training
Number of subjects: 20
Study 34871832 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gaze-based training)
Number of subjects: 20
Study 34707400 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with carbamazepine for four weeks
Number of subjects: 30
Study 34707400 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine only
Number of subjects: 30
Study 36264446 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese-manufactured Glucophage® (500 mg GIR tablet)
Number of subjects: 44
Study 36264446 — intervention group
Group type: COMPARATOR
Intervention: French-manufactured Glucophage® (500 mg GIR tablet)
Number of subjects: 44
Study 32773325 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation plaster (methyl salicylate)
Number of subjects: 168
Study 32773325 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation plaster (indomethacin)
Number of subjects: 168